NCT05987449: An ongoing trial by Hoffmann-La Roche
This trial is ongoing. It must report results 5 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05987449 |
|---|---|
| Title | A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 21, 2023 |
| Completion date | June 16, 2030 |
| Required reporting date | June 16, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |